The Valley Desk

NCT05003986 · Interventional trial

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Overall registry status Recruiting

Phase 2

Conditions Alport Syndrome, Focal Segmental Glomerulosclerosis, IgA Vasculitis, Immunoglobulin A Nephropathy, Minimal Change Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov